SCHEMBL6928801

SCHEMBL6928801

COC(=O)Nc1ccc([N+](=O)[O-])cc1OCCN(C(C)C)C(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.62
HTT P42858 1/20 0.62
ALDH1A1 P00352 7/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
POLB P06746 2/20 0.51
GAA P10253 1/20 0.50
MAPT P10636 6/20 0.49
GLA P06280 1/20 0.49
KDM4E B2RXH2 2/20 0.48
CYP19A1 P11511 2/20 0.48
TSHR P16473 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ATM Q13315 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6928237 0.81 MCHR1 (0.43) SMN1; SMN2GAAMAPT
SCHEMBL4200907 0.80 SMN1; SMN2 (0.52) HTTALDH1A1SMN1; SMN2MAPTCYP19A1
SCHEMBL27884430 0.78 CYP19A1 (0.46) ALDH1A1MAPTCYP19A1TSHRTDP1
SCHEMBL2069934 0.78 PKM (1.00) PKMHTTALDH1A1SMN1; SMN2GAA
SCHEMBL6927122 0.77 CYP19A1 (0.48) HTTCYP19A1TSHRTDP1KMT2A
SCHEMBL14260331 0.76 MCHR1 (0.47) ALDH1A1SMN1; SMN2GAAMAPTKDM4E
SCHEMBL11418021 0.76 CYP19A1 (0.73) PKMHTTALDH1A1SMN1; SMN2POLB
SCHEMBL4667850 0.75 CYP19A1 (0.61) PKMHTTALDH1A1SMN1; SMN2POLB
SCHEMBL11407797 0.74 CYP19A1 (0.71) PKMHTTALDH1A1SMN1; SMN2POLB
SCHEMBL11405969 0.74 CYP19A1 (0.71) PKMHTTALDH1A1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001766-B1 COMPOUNDS FOR THE TREATMENT OF CCR5-MEDIATED DISEASES SMITHKLINE BEECHAM CORP (US) 2003-04-09 EP disclosed
US-6515027-B1 Ligands, agonists or antagonists, of the CC chemokine receptor CC-CKR5 SMITHKLINE BEECHAM CORP. 2003-02-04 US disclosed
EP-1001766-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2001-04-04 EP disclosed
EP-1001766-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-05-24 EP disclosed
WO-1999001127-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1999-01-14 WO disclosed